Certara (NASDAQ:CERT) Shares Down 6.6% – Should You Sell?

Certara, Inc. (NASDAQ:CERT) shares dropped 6.6% during trading on Tuesday. The stock traded as low as $9.44 and last traded at $9.4030. 1,421,391 shares changed hands during trading, a decline of 59% from the average daily volume of 3,494,374 shares. The stock had previously closed at $10.07.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CERT. Barclays lifted their price objective on Certara from $7.50 to $9.00 and gave the company an “equal weight” rating in a research note on Wednesday. UBS Group restated a “neutral” rating and set a $10.00 target price on shares of Certara in a report on Wednesday, September 30th. Finally, Weiss Ratings raised Certara from a “sell (e+)” rating to a “sell (d)” rating in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Certara presently has an average rating of “Hold” and a consensus target price of $8.60.

Certara Price Performance

The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.55 and a current ratio of 2.55. The company has a market cap of $1.37 billion, a PE ratio of -19.91 and a beta of 1.42. The company’s 50-day simple moving average is $8.37 and its 200 day simple moving average is $6.82.

Certara (NASDAQ:CERT) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). The company had revenue of $93.27 million for the quarter, compared to analysts’ expectations of $98.09 million. Certara had a positive return on equity of 3.86% and a negative net margin of 16.75%.The firm’s revenue was down 10.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.07 EPS. On average, sell-side analysts predict that Certara, Inc. will post 0.22 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Certara

Hedge funds have recently bought and sold shares of the stock. Central Pacific Bank Trust Division raised its stake in shares of Certara by 8.7% during the 2nd quarter. Central Pacific Bank Trust Division now owns 19,460 shares of the company’s stock worth $127,000 after buying an additional 1,558 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in Certara by 12.0% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 17,906 shares of the company’s stock valued at $117,000 after acquiring an additional 1,923 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in Certara by 12.1% during the 1st quarter. The Manufacturers Life Insurance Company now owns 23,289 shares of the company’s stock valued at $133,000 after acquiring an additional 2,513 shares in the last quarter. Pacer Advisors Inc. raised its position in Certara by 28.1% during the first quarter. Pacer Advisors Inc. now owns 13,093 shares of the company’s stock worth $75,000 after acquiring an additional 2,871 shares during the last quarter. Finally, PNC Financial Services Group Inc. lifted its holdings in shares of Certara by 22.7% in the first quarter. PNC Financial Services Group Inc. now owns 24,972 shares of the company’s stock valued at $142,000 after purchasing an additional 4,618 shares in the last quarter. Institutional investors and hedge funds own 73.96% of the company’s stock.

Certara Company Profile

Certara, Inc (NASDAQ:CERT) provides software and technology-enabled services for the biopharmaceutical industry. The company helps drug developers use regulatory science, data analysis, and modeling and simulation to support decisions throughout the research, development, and commercialization lifecycle.

Its offerings include software for pharmacokinetic and pharmacodynamic modeling, clinical trial design, patient and disease modeling, regulatory submissions, and real-world data analysis.